|
||
|
||
Back to Policy Library
|
-
Changes
- COVID-19 1.19 Changes
- COVID-19 1.18 Changes
- COVID-19 1.17 Changes
- COVID-19 1.16 Changes
- COVID-19 1.15 Changes
- COVID-19 1.14 Changes
- COVID-19 1.13 Changes
- COVID-19 1.12 Changes
- COVID-19 1.11 Changes
- COVID-19 1.10 Changes
- COVID-19 1.9 Changes
- COVID-19 1.8 Changes
- COVID-19 1.7 Changes
- COVID-19 1.6 Changes
- COVID-19 1.5 Changes
- COVID-19 1.4 Changes
- COVID-19 1.3 Changes
- COVID-19 1.2 Changes
- COVID-19 1.1 Changes
- Table of Contents
- Copyright
- Disclaimer
- Introduction
-
SECTION 01 - ALL HEALTHCARE ORGANIZATIONS
- 1001 - Interim Recommended Infection Prevention and Control (IPC) Practices for Patients with Suspected or Confirmed SARS-CoV-2 Infection
- 1001A - Interim Recommended Routine Infection Prevention and Control (IPC) Practices During the COVID-19 Pandemic
- 1002 - Strategies for Optimizing Supply of N95 Respirators
- 1003 - COVID-19 Interim Guidance - PPE Optimization
- 1004 - COVID-19 Interim Guidance - Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings
- 1005 - COVID-19 Interim Guidance - Death Reporting - Considerations
- 1006 - COVID-19 Interim Guidance - Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019
- 1007 - COVID-19 Interim Guidance - Return to Work Criteria for Healthcare Personnel with Confirmed or Suspected COVID-19 Infection
- 1008 - COVID-19 Interim Guidance - Universal Masking
- 1009 - Uses and Disclosures of Protected Health Information - Film Crews and Media
- 1010 - COVID-19 Interim Guidance - Evaluation and Testing Persons for COVID-19
- 1011 - COVID-19 Pandemic Response - Laboratory Data Reporting
- 1012 - COVID-19 Interim Guidance - Guiding Principles for Contact Tracing
- 1013 - COVID-19 Case Investigation and Contact Tracing PI Outcome Monitoring Form
- 1014 - Healthcare Operations During COVID-19 Pandemic - General Considerations and Best Practices
- 1015 - COVID-19 Interim Guidance - Discontinuation of Isolation Precautions for Patients with COVID-19 in Non-Healthcare Settings
- 1016 - Delivery of Vaccine Services During COVID-19 Pandemic
- 1017 - Interim Considerations for the Potential Management of Anaphylaxis at COVID-19 Vaccination Sites
-
SECTION 02 - LONG TERM CARE
- 2001 - COVID-19 Interim Guidance - Symptom Screening and Transmission Mitigation
- 2002 - COVID-19 Interim Guidance - Infection Prevention and Control for Patients with Suspected or Confirmed COVID-19 in Nursing Homes
- 2003 - COVID-19 Interim Guidance - LTC COVID-19 Mandatory Reporting
- 2004 - COVID-19 Interim Guidance - SARS-CoV-2 Testing in Nursing Homes
- 2005 - COVID-19 Interim Guidance - Testing of Nursing Home Staff and Residents
- 2006 - COVID-19 Interim Guidance - Visitation In Nursing Homes
- 2007 - COVID-19 Interim Guidance - Product/Devices for Source Control
- SECTION 03 - PATIENT AND FAMILY EDUCATION
- SECTION 04 - TELEHEALTH
- SECTION 05 - DIALYSIS FACILITIES
- SECTION 06 - SWING BEDS
- SECTION 07 - HOSPITALS AND CRITICAL ACCESS HOSPITALS